NASDAQ:SNTI | Free Cash Flow | Senti Biosciences Holdings, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2021-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$7.48M
2025-12-31-$6.88M$0.00-$6.88M
2025-03-31-$14.05M$0.00-$14.05M
2024-12-31-$13.5M$11,000.00-$13.52M
2024-03-31-$11.68M$15,000.00-$11.7M
2023-12-31-$7.04M$4,000.00-$7.04M
2023-03-31-$16.3M$6.51M-$22.81M
2022-12-31-$9.01M$8.53M-$17.54M
2022-03-31-$10.06M$7.38M-$17.44M
2021-12-31-$11.97M$3.99M-$15.96M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$43.44M$196,000.00-$43.64M
2024-12-31-$41.4M$26,000.00-$41.42M
2023-12-31-$52.4M$12.04M-$64.43M
2022-12-31-$34.9M$41.37M-$76.27M
2021-12-31-$34.64M$5.54M-$40.18M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.